CLPP and liver cancer: For example, TG42 and TG53, modified analogs of the first ClpP inhibitor trans-β-lactones, inhibit ClpP proteolytic activity, reduce cell migration and induce apoptosis in liver cancer cells (Table 1) [145, 153].